drugset / Trial / NCT00810758

Multiple Oral Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PF-04878691

NCT00810758 ↗

Phase 1 Completed 24 enrolled Pfizer
RandomizedSingle-groupDouble-blindTreatment

Summary

To assess the safety, tolerability, pharmacokinetics and pharmacodynamics of multiple oral doses of PF-04878691.

Timeline

Start
2009-01
Primary completion
2009-11
Completion
2009-11

Drugs

EvaluationDrugModalityDoseRoute
Subject PF-04878691 Unknown 3 mg Oral
Subject PF-04878691 Unknown 6 mg Oral
Subject PF-04878691 Unknown 9 mg Oral